Consistent with this finding, a majority of clinical studies showed that the upregulated expression of AIB1 was correlated with tumor aggressiveness and/or poor patient prognosis in a series of human hormone-independent malignancies, including gliomas 21, gastric 22, hepatocellular23, and colorectal carcinomas 24. The gene discussed is NCOA3; the disease is colorectal carcinoma.